Advancing the science and practice of sleep medicine through evidence-based insights and data-driven analysis.
Filter
Category
Content type
Continuity of sleep care
The missing link: Re-engagement and continuity in OSA care
OSA is chronic yet care systems treat drop-off as an endpoint. Re-engagement and continuity pathways are essential to improving outcomes and reducing inequities.
Why the OSA journey needs long-term, adaptive treatment models
OSA is chronic and affects nearly a billion people, yet care remains rigid and binary. It’s time for a model that’s flexible and supports long-term care.
OSA is a prevalent yet underdiagnosed disease, currently affecting over 50 million adults in the United States, yet up to 80% of cases remained undiagnosed1, 2 — demanding urgent action to close the care gap.
The economic value of treating OSA with PAP therapy
By reducing acute care costs and improving management of high-cost comorbidities, PAP therapy offers a compelling opportunity to reduce total cost of care.
Immediate action is needed by multiple sleep stakeholders to ensure the future burden of OSA can be clinically managed by sleep specialists and primary care providers (PCPs)
How P4 medicine can improve diagnosis and treament of OSA
Current approaches to OSA leave many struggling, often going undiagnosed and untreated. A P4 mindset can shift thinking to identify at-risk patients earlier.
The value of clinical trial and real-world data together
RWE with RCTs blends theory with practice to increase patient representation and identify long-term trends, enhancing the ability to advance patient care.
